Share Twitter LinkedIn Facebook Email Lisa Shnayder, MD of the University of Kansas Medical Center discusses the new cost saving technologies for reconstructing a mandible after cancer treatment at ASTRO Head and Neck Symposium 2016.
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read
Spotlight on CAR T-cell Therapy in 2024: Advances & Clinical Insights Acute Lymphoblastic Leukemia 3 Mins Read